FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics. A pharmaceutical aerosol composition in the form of a solution for an aerosol metered-dose inhaler is described. The composition contains glycopyrronium chloride dissolved in HFA propellant, and a co-solvent representing ethanol. The invention also refers to using the above composition for producing a medicinal product and to a method for aerosol container charge with the above composition.
EFFECT: invention provides the extended shelf life of the above composition.
8 cl, 3 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATION TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2010 |
|
RU2561052C2 |
| MEASURED DOSE INHALER WITH COMPRESSED AIR SPRAYING, CONTAINING BUFFERED PHARMACEUTICAL COMPOSITION | 2021 |
|
RU2792689C2 |
| TROVENTOL-BASED COMPOSITION | 2006 |
|
RU2457832C2 |
| PHARMACEUTICAL AEROSOL COMPOSITION | 2009 |
|
RU2565438C2 |
| COMPRESSED AIR METERED-DOSE INHALER CONTAINING A BUFFERED PHARMACEUTICAL COMPOSITION | 2021 |
|
RU2795000C2 |
| CRYSTALLINE MICRO PARTICLES OF BETA-AGONIST, COATED WITH FATTY ACID | 2012 |
|
RU2629085C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING ARFORMOTEROL AND FLUTICASONE FUROATE | 2013 |
|
RU2678992C2 |
| CRYSTALLINE LEVOSALBUTAMOL SULFATE, METHOD OF ITS OBTAINING AND PHARMACEUTICAL COMPOSITION, WHICH CONTAINS IT | 2005 |
|
RU2440972C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING RPL554 IN HFA-134A FOR ADMINISTRATION BY INHALATION | 2019 |
|
RU2813959C2 |
| COMPOSITIONS, METHODS AND SYSTEMS FOR RESPIRATORY DELIVERY OF TWO OR MORE ACTIVE AGENTS | 2010 |
|
RU2586297C2 |
